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Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common liver disease of
industrialized countries. Thus, discovering food components that can ameliorate NAFLD is of interest. Lotus root,
the edible rhizome of Nelumbo nucifera, contains high levels of polyphenolic compounds, and several health-
promoting properties of lotus root have been reported. In this study, we tested whether feeding a polyphenolic
extract of lotus root to db/db mice protects them from hepatic steatosis.
Results: After 3 weeks of feeding, the hepatomegaly and hepatic triglyceride accumulation were markedly
alleviated in the lotus polyphenol-diet-fed db/db mice relative to the control mice. Although the lipolytic enzyme
activity was not changed, the activities of lipogenic enzymes, such as fatty acid synthase and malic enzyme, were
significantly lower in the lotus polyphenol diet-fed db/db mice. Additionally, the ESI-IT/MS and MALDI-TOF MS
spectra revealed the presence of B-type proanthocyanidin polymers with polymerization degree up to 9 in the
polyphenolic lotus root extract.
Conclusion: We speculate that the condensed tannins contained in lotus root can alleviate hepatic steatosis by
suppressing the lipogenic enzyme activity in the livers of db/db mice.
Background
Nonalcoholic fatty liver disease (NAFLD) is often asso-
ciated with features of the metabolic syndrome and is
emerging as the most common liver disease worldwide
[1-4]. NAFLD is the preferred term for describing the
spectrum of liver damage that ranges from hepatic stea-
tosis to steatohepatitis, liver fibrosis, and cirrhosis. Most
of the liver-related morbidity and mortality are asso-
ciated with the development of cirrhosis, which is most
likely to occur in individuals who have progressed from
hepatic steatosis to steatohepatitis. The processes by
which steatohepatitis evolves from hepatic steatosis are
not fully understood; nevertheless, developing effective
therapies for treating NAFLD is necessary, and discover-
ing nutrients that can reduce the risk of NAFLD would
be useful. db/db mice suffer from hyperphagia, because
they have a missense mutati o no nt h el e p t i nr e c e p t o r
gene. They develop a syndrome that involves multiple
metabolic and hormonal disorders, including NAFLD,
and shares many features with human metabolic syn-
drome [5-7].
Diet has been recognized as factor that contributes to
the development and prevention of NAFLD [8-11], and
polyphenol-rich plants and fruits have been used in folk
medicines throughout the world for treating lifestyle-
related diseases [12-14]. Nelumbo nucifera is a plant in
the monogeneric family Nelumbonaceae.I t sr h i z o m e
(lotus root) is recognized in eastern countries as one of
the most delicious and nutritional vegetables, and it has
also been used in traditional Asian herbal medicine.
There are several studies showing that lotus root con-
tains high levels of polyphenolic compounds and pos-
sesses several beneficial health properties, such as
hypoglycemic, anti-inflammatory and antioxidant activ-
ities [15-18]. Our previous study showed that feeding
lotus root powder prevents the development of NAFLD
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present study, we evaluated the effect of a diet supple-
mented with a polyphenolic extract of lotus root on the
development of NAFLD in db/db mice. Additionally, the
structures of the polyphenolic lotus root extract were
characterized through analyses combining a butanolic-
HCl assay, electrospray-ionization mass spectrometry
(ESI/MS), and matrix-assisted laser-desorption ioniza-
tion time-of-flight mass spectrometry (MALDI-TOF
MS).
Materials and methods
Animals and diets
All aspects of the experiment were conducted according
to the guidelines provided by the ethical committee for
experimental animal care of Saga University. Six-week-
old male db/db mice (C57BLKS/J Iar-+Lepr
db/+Lepr
db)
were purchased from Japan SLC (Shizuoka, Japan). The
mice were housed individually in plastic cages in a tem-
perature-controlled room (24°C) under a 12-h light/dark
cycle. The basal semisynthetic diets were prepared
according to the recommendations of the AIN-76 [19]
(Table 1). The freeze-dried lotus root powder were pro-
vided by the Industrial Technology Center of Saga and
the preparation of the polyphenolic lotus root extract
was performed as shown in Figure 1. Approximately 16 g
of polyphenolic extract was obtained from 1000 g of
freeze-dried lotus root powder, and the extract included
892 mg/g [(+)-catechin equivalent] total polyphenolic
substances, as estimated by the Folin-Ciocalteu method
[20]. The db/db mice were assigned to two groups (of six
mice each) that were fed one of two diets (Table 1): a
semisynthetic AIN-76 diet (the control group) or a semi-
synthetic AIN-76 diet supplemented with 0.5% lotus root
polyphenol at the expense of sucrose (the lotus polyphe-
n o lg r o u p ) .T h em i c ew e r ep a i r - f e dt h ed i e t sf o r3w e e k s
using the Rodent CAFE (KBT Oriental Co. Ltd., Saga,
Japan). At the end of the feeding period and after a 9-h
starvation period, the mice were sacrificed under
pentobarbital sodium salt anesthesia by exsanguination
from the heart. The white adipose tissue (WAT) and the
livers were excised immediately, and the serum was sepa-
rated from the blood.
Measurement of the triglyceride and cholesterol levels in
the liver
The liver lipids were extracted according to the method
of Folch et al. [21], and the concentrations of triglycer-
ide and cholesterol were measured using the methods of
Fletcher [22] and Sperry & Webb [23], respectively.
Measurement of the serum parameters
The serum triglyceride and cholesterol levels were mea-
sured using commercial enzyme assay kits (Wako Pure
Chemicals, Tokyo, Japan). The serum glutamic pyruvic
transaminase (GPT) and alkaline phosphatase (ALP)
activities were measured using commercial enzyme
assay kits (Wako Pure Chemicals, Tokyo, Japan).
Assays of the hepatic enzyme activity
The enzyme activities of fatty acid synthase (FAS) [24] and
malic enzyme [25] in the cytosomal fraction and of carni-
tine palmitoyltransferase (CPT) [26] in the mitochondrial
fraction were determined as has been described elsewhere.
The protein concentration of each fraction was deter-
mined according to the method of Lowry et al. [27], with
bovine serum albumin used as the standard.
Lotus root polyphenol analysis
First, a colorimetric butanolic-HCl assay for procyanidins
was employed to assess the polyphenolic lotus root
extracts; it used procyanidinB2 as the positive standard
and (+)-catechin as the negative standard [28]. Second, a
structural analysis of the lotus root polyphenol compo-
nents was conducted by direct-infusion ESI/MS. The ESI/
MS spectrometry was performed using a HCT-Ultra sys-
tem (Bruker Daltnics GmbH, Bremen, Germany). The
sample was dissolved in 50% methanol (1 mg/mL) and
directly infused into the ESI/MS system at 0.2 mL/h with
a syringe pump. The analytical conditions of the ESI/MS
were as follows: ion mode, negative; capillary voltage,
4 kV; capillary exit, -241 V; nebulizing gas, 45 psi; flow
rate of dry gas, 10 L/min; dry temperature, 350°C; an scan
range, 100-3,000 m/z. Finally, a MALDI-TOF MS analysis
was performed to obtain further lotus root polyphenol
structural information. The MALDI-TOF MS analysis was
conducted using an Autoflex III Smartbeam system (Bru-
ker Daltnics GmbH, Bremen, Germany). The sample was
dissolved in 50% methanol (2 mg/mL) and premixed with
2,5-dihydroxybenzoic acid (20 mg/mL in 50% acetonitrile
containing 0.1% trifluoroacetic acid) and sodium trifluor-
oacetate (2 mg/mL in acetonitrile) at a ratio of 2:10:1.
Then, 1 μL of the premixed sample solution was deposited
Table 1 The composition of the experimental diets
Ingredients Control Lotus polyphenol
%
Casein 20.0 20.0
Corn starch 15.0 15.0
Cellulose 5.0 5.0
Mineral mixture (AIN 76) 3.5 3.5
Vitamin mixture (AIN 76) 1.0 1.0
DL-Methionine 0.3 0.3
Choline bitartrate 0.2 0.2
Corn oil 5.0 5.0
Lotus root polyphenol - 0.5
Sucrose 50.0 49.5
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dry at room temperature. The analytical conditions of the
MALDI-TOF MS analysis were as follows: ion mode,
reflector positive; ion source 1 voltage, 19 kV; ion source 2
voltage, 16.85 kV; lens voltage, 8.7 kV; paused ion extrac-
tion, 100 ns; and mass range, 500-3,000 m/z. The mass
spectra were acquired by averaging 1,000 laser shots.
Statistical analysis
All of the values are expressed as the means ± standard
error. The significance of the differences between the
means of the two groups was determined by the Stu-
dent’s t-test. Differences were considered to be signifi-
cant at p < 0.05.
Results and Discussion
NAFLD is common in type 2 diabetic and obese
patients. Although the mechanisms responsible for the
development of NAFLD are unclear, it has been sug-
gested that hepatic steatosis results from increased
lipogenesis and/or decreased lipolysis, in addition to the
accelerated mobilization of the expanded visceral WAT
fat to the liver [2,3].
Effects of the lotus polyphenol diet on growth
parameters in db/db mice
The two groups of db/db mice did not differ in their
initial body weight, nor did they differ in their final
body weight, food intake, or total WAT weight during
and after the 3-week feeding period (Table 2). By con-
trast, the relative liver weight and hepatic triglyceride
concentration differed between the db/db mice fed the
control and lotus polyphenol diets (Figure 2).
Effects of Lotus polyphenol diet on hepatic lipids in db/
db mice
The relative liver weight was 15% less in the lotus poly-
phenol diet-fed db/db mice, and this lower liver weight
was associated with markedly less (62%) triglyceride
accumulation in the liver (Figure 2). However, the
 
Figure 1 Preparation of the polyphenolic extracts from the lotus root powder.
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two groups (control group, 2.98 ± 0.19 mg/g liver; lotus
polyphenol group, 3.49 ± 0.21 mg/g liver).
Effects of the lotus polyphenol diet on serum parameters
in db/db mice
The serum cholesterol levels and triglyceride levels were
not different between the two groups (Table 3). Consis-
tent with alleviation of the hepatomegaly and hepatic
steatosis by the lotus polyphenol diet, the activities of
hepatic injury markers, such as GPT and ALP, tended to
be lower (by 24% and 17%, respectively) in the sera of the
lotus polyphenol diet-fed db/db mice than in the sera of
the control diet-fed db/db mice (Table 3). These results
s u g g e s tt h a tt h ep o l y p h e n o lic lotus root extract can pre-
vent the development of NAFLD in the db/db mice.
Effects of the lotus polyphenol diet on enzyme activity
related to lipid metabolism in the livers of db/db mice
To further examine the effect of the lotus polyphenol
diet on the liver, the hepatic enzymes related to
triglyceride metabolism were analyzed (Figure 3).
Although the activity of CPT (a key enzyme in fatty acid
b-oxidation) was not changed, the activities of FAS and
malic enzyme (lipogenic enzymes related to de novo
fatty acid biosynthesis) were significantly lower in the
lotus polyphenol diet-fed db/db mice. Previous studies
have demonstrated that dietary polyphenols suppress
lipogenesis. Previous reports have indicated that poly-
phenols from plants have FAS inhibitory activity in vitro
[29], and we have reported that feeding tea catechins
(which are rich in (-)-epigallocatechin gallate and
(-)-epicatechin gallate) to rats results in reduced visceral
fat deposition through a reduction of hepatic FAS activ-
ity [30]. Given that the lotus root powder in our pre-
vious study also suppressed hepatic FAS activity, we
speculate that the ameliorative effect of lotus root on
hepatic steatosis in db/db mice is partly attributable to
the suppression of hepatic lipogenic enzyme activity by
the lotus root polyphenols.
Lotus root polyphenol analysis
The colorimetric butanoic-HCl assay showed that the poly-
phenolic lotus root extract contained proanthocyanidins
Table 2 The effect of polyphenolic lotus root extract on
growth parameters in db/db mice
Control Lotus polyphenol
Initial body weight (g) 33.7 ± 0.6 33.7 ± 0.5
Final body weight (g) 37.4 ± 0.6 35.8 ± 1.7
Food intake (g) 109 ± 3 109 ± 1
White adipose tissue weight (g/100 g body weight)
Total 6.92 ± 0.12 6.53 ± 0.25
Epididymal 4.30 ± 0.12 4.10 ± 0.14
Perirenal 2.61 ± 0.06 2.43 ± 0.13
The values are expressed as the mean ± standard error for six mice.
Figure 2 The relative liver weights and hepatic triglyceride levels in the db/db mice. The mice were fed the control diet or the lotus root
polyphenol diet for 3 weeks. The values are expressed as the mean ± standard error for six mice. See Table 1 for the composition of the diets. *
Significant (P < 0.05) difference between the control and lotus polyphenol groups of db/db mice.
Table 3 The effect of polyphenolic lotus root extract on
serum parameters in db/db mice.
Control Lotus polyphenol
Triglyceride (mg/dL) 99.8 ± 9.1 106 ± 14
Cholesterol (mg/dL) 166 ± 15 182 ± 10
ALP (IU/L) 40.3 ± 5.5 30.7 ± 2.9
GPT (IU/L) 110 ± 17 91.5 ± 4.6
The values are expressed as the mean ± standard error for six mice.
GPT, glutamic pyruvic transaminase; ALP, alkaline phosphatase.
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terized by ESI/MS and MALDI-TOF MS spectrometry.
The ESI/MS spectra were recorded in the negative ion
mode, which detects proanthocyanidin molecules better
detected than the positive ion mode, and they showed the
existence of epi/catechin, epi/gallocatechin, and B-type
proanthocyanidins (Figure 5). The degree of polymerization
of proanthocyanidin was calculated by the formula of B-
type proanthocyanidin mass calculation. Additionally, both
procyanidin (polymeric tannins composed of catechin) and
prodelphinidin (polymeric tannins composed of gallocate-
chin) homopolymers and as a complex series of procyani-
din-prodelphinidin heteropolymers with polymerization
degree up to 9 were detected through the MALDI-TOF
MS analysis (Figure 6). The putative structure of the
condensed tannins in the polyphenolic lotus root extract is
illustrated in Figure 7. There are several studies reporting
that proanthocyanidins possess various in vivo physiologi-
cal properties, such as antioxidant, anti-carcinogenesis, and
anti-inflammatory activities [31-33]. Additionally, previous
reports have indicated that dietary proanthocyanidins have
hypolipidemic properties and that proanthocyanidins from
grape seed and persimmon peel down-regulate the expres-
sion of lipogenic genes by reducing the steroid response
element binding protein 1 transcription factor [34-36].
Deprez et al. have shown that proanothocyanidin dimmers
and trimmers have similar permeability coefficients in
Caco-2 cells [37], and absorption of dimeric and trimeric
procyanidins has been demonstrated in rat and human
sera [38-40]. Further investigation in future studies will be
Figure 3 The activities of the hepatic enzymes related to triglyceride metabolism in the db/db mice. The mice were fed the control diet
or the lotus root polyphenol diet for 3 weeks. The values are expressed as the mean ± standard error for six mice. See Table 1 for the
composition of the diets. * Significant (P < 0.05) difference between the control and lotus polyphenol groups of db/db mice. FAS, fatty acid
synthase; CPT, carnitine palmitoyltransferase; ME, malic enzyme.
Figure 4 A qualitative analysis of the lotus root polyphenols by the HCl-butanolic method. The reaction mixtures consisted of 0.02 mg of
(+)-catechin, proanthocyanidin B2, and lotus polyphenols in 500 μl of HCl-butanol (concentrated HCl/n-butanol, 1:5) were heated at100°C for
30 min.
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phenol and the precise mechanisms of its in vivo physiolo-
gical properties.
Conclusion
Although further qualitative and quantitative analyses of
lotus root polyphenols are necessary, the present results
suggest that the ameliorative effect of dietary lotus root
on hepatic steatosis in db/db mice is attributable to the
suppression of hepatic lipogenesis by the lotus root
polyphenols.
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